Many research studies have shown that the suppression of NRF2-related antioxidant mechanisms is a viable approach for inducing pro-oxidizing conditions in the tumor microenvironment and can trigger reactive oxygen species (ROS)-induced cell death in a variety of tumors and organs. Here, NFE2L2 is linked to neoplasm.